Pfizer–biontech COVID-19 RNA vaccination induces phosphatidylserine autoantibodies, cryoglobulinemia, and digital necrosis in a patient with pre-existing autoimmunity by Sandy Nasr, Sara Khalil, Bernard J. Poiesz, Katalin Banki, Andras Perl

“…We describe a 64-year-old Caucasian female with a history of Raynaud's disease, hand arthritis, photosensitivity, Sjogren's syndrome and leukocytoclastic vasculitis who presented with progressively worsening fingertip necrosis that began three days after receiving a first dose of Pfizer–BioNTech COVID-19 RNA vaccine. Our workup revealed cryoglobulinemia, hypocomplementemia, elevated antinuclear antibodies (ANA) and IgM antiphospholipid autoantibodies (aPL) directed against phosphatidylserine (aPL-PS), suggesting a diagnosis of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). …”
Get full text

Delayed inflammatory reaction to hyaluronic acid lip filler after the Pfizer-BioNTech COVID-19 vaccine: A case report by Thikryat Neamatallah

Subjects: Get full text

Recurrent giant cellulitis-like sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine by Penelope Hirt, Lily Park, Carly E. Wallace, Francisco Kerdel

Get full text

A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association? by Francesca Ambrogio, Carmelo Laface, Giorgia Sbarra, Raffaele Filotico, Girolamo Ranieri, Chiara Barlusconi, Aurora De Marco, Gerardo Cazzato, Domenico Bonamonte, Paolo Romita, Caterina Foti

“…In this paper, we report a clinical case of Purpura Annularis Telangiectodes of Majocchi following a third-dose administration of the Pfizer-BioNTech COVID-19 vaccine. Almost 30 days after the third dose, the patient presented erythematous annular patches on the lower limbs with purpuric peripheral areas and a central clearing with no other symptoms. …”
Get full text

Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate by Jesús Hermosilla, Airan Alonso-García, Antonio Salmerón-García, José Cabeza-Barrera, Antonio L. Medina-Castillo, Raquel Pérez-Robles, Natalia Navas

Get full text

TROMBOCITOPENIA IMUNE ASSOCIADA À IMUNIZAÇÃO PARA SARS-COV-2 COM IMUNIZANTE DA PFIZER: UM RELATO DE CASO by TAS Pereira, JVV Costardi, RNS Antunes

“…Casos de trombocitopenia imune associados à imunização contra SARS-CoV-2, incluindo a vacina BNT16B2b2 mRNA da Pfizer, foram descritos. Relato de caso: Um homem de 38 anos, previamente hígido e que não fazia uso de qualquer medicamento, recebeu a vacina PfizerBioNTech BNT16B2b2 mRNA. …”
Get full text

Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records by Vladimir Atanasov, Natalia Barreto, Jeff Whittle, John Meurer, Benjamin W. Weston, Qian (Eric) Luo, Andy Ye Yuan, Lorenzo Franchi, Ruohao Zhang, Bernard Black

Subjects: Get full text

Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review by Karen Cortés-Sarabia, Mayralina Gutiérrez-Torres, Escarlet Maleny Mendoza-Renteria, Marco Antonio Leyva-Vázquez, Amalia Vences-Velázquez, Daniel Hernández-Sotelo, Fredy Omar Beltrán-Anaya, Oscar Del Moral-Hernández, Berenice Illades-Aguiar

“…The BNT162b2 Pfizer/BioNTech vaccine was the first emergency approved vaccine during the COVID-19 pandemic. …”
Get full text

Friend or foe—The Pfizer‐BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis by Bianca Maria Wahlen, Ruben Peralta, Hassan Al‐Thani, Ayman El‐Menyar

“…A 52‐year‐old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer‐BioNTech COVID‐19 vaccination. The symptoms subsided completely with conservative treatment for 12 days, and the ultrasound and laboratory findings went back to normal.…”
Get full text

Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2 by Robles Navas Leandra J., Ortega Huete Juan J., Juliá Sanchis María L., Bravo Miró Jorge S., Cervera Sánchez Serezade, Molina Gasset Ricardo

“…To assess the immunity of healthcare and non-healthcare workers in the Alcoy health area (Spain) after completing three doses of the Pfizer-BioNTech vaccine and how it relates with individual factors.…”
Get full text

Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review by Lia Reynolds, Cate Dewey, Ghaid Asfour, Matthew Little, Matthew Little

“…The purpose of this systematic review was to report on the vaccine efficacy (VE) of three SARS-CoV-2 vaccines approved by Health Canada: Pfizer BioNTech, Moderna, and AstraZeneca. Four databases were searched for primary publications on population-level VE. …”
Get full text

A Rare Case of Longitudinally Extensive Transverse Myelitis Following Pfizer-BioNTech COVID-19 Vaccination with a Favourable Outcome by Ojbindra KC, Punya Hari Dahal, Manisha Koirala, Sumeet Kumar Yadav

“…Case Description: We report the case of 50-year-old man who presented with progressive lower extremity weakness, back pain and urinary retention after his second dose of the Pfizer COVID-19 vaccine. MRI of the spine revealed longitudinally extensive transverse myelitis (LETM). …”
Get full text

Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia by Edrous Alamer, Abdulaziz Alhazmi, Naaif A. Qasir, Rahaf Alamer, Halima Areeshi, Gassem Gohal, Marwa Qadri, Anwar M. Hashem, Abdullah Algaissi

Subjects: Get full text

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years by Gili Joseph, Elisheva Klein, Yaniv Lustig, Yael Weiss-Ottolenghi, Keren Asraf, Victoria Indenbaum, Sharon Amit, Or Kriger, Mayan Gilboa, Yuval Levy, Itai M. Pessach, Yitshak Kreiss, Gili Regev-Yochay, Michal Stein

“…A total of 110 children, 5–11 years old were vaccinated with two doses (with a 3-week interval between doses) of the Pfizer-BioNTech COVID-19 vaccine and were followed for 21, 90, and 180 days after vaccination for immunogenicity, adverse events, and breakthrough infections. …”
Get full text

Emotional profiling and cognitive networks unravel how mainstream and alternative press framed AstraZeneca, Pfizer and COVID-19 vaccination campaigns by Alfonso Semeraro, Salvatore Vilella, Giancarlo Ruffo, Massimo Stella

“…Initially, mainstream news linked mostly “Pfizer” with side effects (e.g. “allergy”, “reaction”, “fever”). …”
Get full text

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups by Whitaker, HJ, Tsang, RSM, Byford, R, Andrews, NJ, Sherlock, J, Sebastian Pillai, P, Williams, J, Button, E, Campbell, H, Sinnathamby, M, Victor, W, Anand, S, Linley, E, Hewson, J, DArchangelo, S, Otter, AD, Ellis, J, Hobbs, RFD, Howsam, G, Zambon, M, Ramsay, M, Brown, KE, de Lusignan, S, Amirthalingam, G, Lopez Bernal, J

“…Reduced vaccine effectiveness against clinical disease was also noted in the immunosuppressed group; after a second dose, effectiveness was moderate (Pfizer: 59.6%, 95%CI 18.0-80.1%; AstraZeneca 60.0%, 95%CI -63.6-90.2%).…”

Vaccinating with a COVID-19 Vaccine: Experience of the Tertiary Allergology Center by Eglė Žilėnaitė, Laura Malinauskienė, Kęstutis Černiauskas, Linas Griguola, Kotryna Linauskienė, Violeta Kvedarienė, Anželika Chomičienė

Subjects: Get full text

Safety and efficacy of coronavirus disease‐19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review by Neha Mehta, Sangam Shah, Kiran Paudel, Rajan Chamlagain, Santosh Chhetri

Subjects: Get full text

Analyses of Public Attention and Sentiments towards Different COVID-19 Vaccines Using Data Mining Techniques by Muhammad Faheem Mushtaq, Mian Muhammad Sadiq Fareed, Mubarak Almutairi, Saleem Ullah, Gulnaz Ahmed, Kashif Munir

Subjects: Get full text

A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18 by Mohamad Nour Alhosaini

Subjects: Get full text